APOC3 drugs for Severe Hypertriglyceridemia
5 tracked APOC3 drugs in the Severe Hypertriglyceridemia race. The class explanation lives on the APOC3 page; the full indication pipeline across every mechanism is on the Severe Hypertriglyceridemia page.
1 approved / phase 41 Phase 32 Phase 21 Phase 1
Head-to-head evidence: CS-121 vs Olezarsen · CS-121 vs Plozasiran · HRS-7249 vs Olezarsen · HRS-7249 vs Plozasiran · ION775 vs Olezarsen · ION775 vs Plozasiran